Published in PLoS One on January 25, 2011
Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010. PLoS One (2011) 0.95
High incidence of severe influenza among individuals over 50 years of age. Clin Vaccine Immunol (2011) 0.94
Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population. PLoS One (2013) 0.90
Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody. PLoS One (2013) 0.86
Prospective study of avian influenza virus infections among rural Thai villagers. PLoS One (2013) 0.86
Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand. Hum Vaccin Immunother (2012) 0.84
Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid. J Virol (2016) 0.77
Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response. PLoS One (2016) 0.76
Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection. J Infect Dis (2015) 0.76
High rate of A(H1N1)pdm09 infections among rural Thai villagers, 2009-2010. PLoS One (2014) 0.76
Seroincidence of Influenza Among HIV-infected and HIV-uninfected Men During the 2009 H1N1 Influenza Pandemic, Bangkok, Thailand. Open Forum Infect Dis (2014) 0.75
Amino acid substitutions in hemagglutinin of the 2009 pandemic influenza A(H1N1) viruses that might affect the viral antigenicity. BMC Res Notes (2014) 0.75
Serological survey of canine H3N2, pandemic H1N1/09, and human seasonal H3N2 influenza viruses in cats in northern China, 2010-2014. Virol J (2015) 0.75
Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 15.02
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet (2010) 12.43
H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet (2009) 12.32
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol (1999) 11.94
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
The 1918 influenza pandemic: insights for the 21st century. J Infect Dis (2007) 4.99
Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ (2009) 4.31
Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill (2009) 3.30
Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol (2003) 3.23
Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) (2003) 3.16
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis (2009) 2.13
Low frequency of infection with avian influenza virus (H5N1) among poultry farmers, Thailand, 2004. Emerg Infect Dis (2008) 1.67
Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza. PLoS Curr (2010) 1.57
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine (2008) 1.55
Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study. PLoS One (2010) 1.48
Seroprevalence of antibodies to avian influenza virus A (H5N1) among residents of villages with human cases, Thailand, 2005. Emerg Infect Dis (2009) 1.35
Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine (2006) 1.28
On the use of hemagglutination-inhibition for influenza surveillance: surveillance data are predictive of influenza vaccine effectiveness. Vaccine (2009) 1.23
Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection. J Gen Virol (2008) 1.21
Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans. Clin Vaccine Immunol (2009) 1.17
Serological surveys for 2009 pandemic influenza A H1N1. Lancet (2010) 1.16
Erythrocyte binding preference of avian influenza H5N1 viruses. J Clin Microbiol (2007) 1.08
Antibodies specific to the HA2 glycopolypeptide of influenza A virus haemagglutinin with fusion-inhibition activity contribute to the protection of mice against lethal infection. J Gen Virol (2007) 1.07
Mortality and morbidity burden associated with A/H1N1pdm influenza virus. PLoS Curr (2009) 0.99
Severe novel influenza A (H1N1) infection in cancer patients. Ann Oncol (2010) 0.98
Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients. Viral Immunol (2010) 0.84
Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (2005) 30.92
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med (2009) 28.62
Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med (2005) 14.59
Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 10.27
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N Engl J Med (2015) 4.79
Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J Gen Virol (2005) 3.63
The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling. PLoS Med (2009) 3.26
Influenza A H5N1 replication sites in humans. Emerg Infect Dis (2005) 3.21
An avian influenza H5N1 virus that binds to a human-type receptor. J Virol (2007) 2.77
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. Lancet Infect Dis (2012) 2.68
Transparent development of the WHO rapid advice guidelines. PLoS Med (2007) 2.57
Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol (2005) 2.56
A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet (2005) 2.31
Evaluation of an NS1 antigen detection for diagnosis of acute dengue infection in patients with acute febrile illness. Diagn Microbiol Infect Dis (2008) 2.06
Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol (2008) 1.96
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. Vaccine (2005) 1.96
Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children. AIDS (2014) 1.91
Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest (2004) 1.89
Chikungunya in Southeast Asia: understanding the emergence and finding solutions. Int J Infect Dis (2011) 1.87
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis (2007) 1.85
Avian influenza virus infection of children in Vietnam and Thailand. Pediatr Infect Dis J (2004) 1.83
Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J Virol (2012) 1.74
Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis (2007) 1.72
Cohort profile: the TREAT Asia pediatric HIV observational database. Int J Epidemiol (2010) 1.70
One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion (2009) 1.68
Low frequency of infection with avian influenza virus (H5N1) among poultry farmers, Thailand, 2004. Emerg Infect Dis (2008) 1.67
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis (2011) 1.66
Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J Virol (2008) 1.65
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E. J Infect Dis (2012) 1.65
Aerosol transmission is an important mode of influenza A virus spread. Nat Commun (2013) 1.56
A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J (2005) 1.55
Evaluating programs to prevent mother-to-child HIV transmission in two large Bangkok hospitals, 1999-2001. J Acquir Immune Defic Syndr (2005) 1.54
Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection. J Infect Dis (2008) 1.53
High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol (2007) 1.49
A novel mutation of the CYBB gene resulting in severe form of X-linked chronic granulomatous disease. Asian Pac J Allergy Immunol (2007) 1.41
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate. PLoS One (2010) 1.41
Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis (2005) 1.41
Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J (2007) 1.39
Uncoating of HIV-1 requires cellular activation. Virology (2005) 1.36
Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr (2015) 1.33
Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults. J Infect Dis (2003) 1.33
Clinical performance of a rapid influenza test and comparison of nasal versus throat swabs to detect 2009 pandemic influenza A (H1N1) infection in Thai children. Pediatr Infect Dis J (2010) 1.32
Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN). PLoS Med (2010) 1.32
Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults. Vaccine (2009) 1.30
Detection of dengue virus in platelets isolated from dengue patients. Southeast Asian J Trop Med Public Health (2009) 1.29
Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine (2006) 1.28
Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database. J Acquir Immune Defic Syndr (2010) 1.25
Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr (2011) 1.24
Modeling seasonal leptospirosis transmission and its association with rainfall and temperature in Thailand using time-series and ARIMAX analyses. Asian Pac J Trop Med (2012) 1.19
The complex relationship between weather and dengue virus transmission in Thailand. Am J Trop Med Hyg (2013) 1.18
Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol (2007) 1.17
Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans. Clin Vaccine Immunol (2009) 1.17
Positive selection at the receptor-binding site of haemagglutinin H5 in viral sequences derived from human tissues. J Gen Virol (2008) 1.17
The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor. Antiviral Res (2007) 1.17
Revisiting Rayong: shifting seroprofiles of dengue in Thailand and their implications for transmission and control. Am J Epidemiol (2013) 1.16
Usage of dried blood spots for molecular diagnosis and monitoring HIV-1 infection. J Virol Methods (2005) 1.16
Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand. Proc Natl Acad Sci U S A (2013) 1.15
Diagnosis disclosure in HIV-infected Thai children. J Med Assoc Thai (2005) 1.13
Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J Virol (2008) 1.13
Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J (2008) 1.13
Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics (2002) 1.11
A re-evaluation of the mechanisms leading to dengue hemorrhagic fever. Ann N Y Acad Sci (2009) 1.10
Respiratory syncytial virus-associated lower respiratory tract infection in under-5-year-old children in a rural community of central Thailand, a population-based study. J Med Assoc Thai (2002) 1.09
Erythrocyte binding preference of avian influenza H5N1 viruses. J Clin Microbiol (2007) 1.08
Blood screening for influenza. Emerg Infect Dis (2007) 1.07
A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand. Pediatr Infect Dis J (2010) 1.05
A review on the clinical spectrum and natural history of human influenza. Int J Infect Dis (2012) 1.04
The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. J Med Assoc Thai (2005) 1.04
Development of a diagnosis disclosure model for perinatally HIV-infected children in Thailand. AIDS Care (2012) 1.04
Influenza virus contamination of common household surfaces during the 2009 influenza A (H1N1) pandemic in Bangkok, Thailand: implications for contact transmission. Clin Infect Dis (2010) 1.04
Space-time analysis of hospitalised dengue patients in rural Thailand reveals important temporal intervals in the pattern of dengue virus transmission. Trop Med Int Health (2012) 1.04
Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005. Vaccine (2006) 1.03
A cross-sectional study of pre-travel health-seeking practices among travelers departing Sydney and Bangkok airports. BMC Public Health (2012) 1.02
Influenza A viral loads in respiratory samples collected from patients infected with pandemic H1N1, seasonal H1N1 and H3N2 viruses. Virol J (2010) 1.01